Back to MNPR
TCG Crossover Management, LLC → MNPR
TCG Crossover Management, LLC MNPR Position History
Monopar Therapeutics Inc. • Healthcare
Quarters held
4
Latest value
$16.1M
Q3 2026
Peak value
$18.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $9.3M |
| Q1 2026 | $7.2M |
| Q2 2026 | $18.8M |
| Q3 2026 | $16.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $16.1M | 202.2K | — | — |
| Q2 2026 | $18.8M | 203.3K | — | — |
| Q1 2026 | $7.2M | 132.1K | — | — |
| Q4 2025 | $9.3M | 141.9K | — | — |
Other funds holding MNPR
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC